Does adaptimmune Therapeutics plc pay a dividend?

Adaptimmune Therapeutics plc was founded in 2008 and is headquartered in Abingdon, the United Kingdom. ADAP does not currently pay a dividend. Go Premium to see ratings on ADAP peers. Is Adaptimmune Therapeutics plc (ADAP) a buy, sell, or hold?

What does adaptimmune Therapeutics (ADAP) do?

The Company develops novel cancer immunotherapy products based on T-cell receptor platform that helps to identify cancer targets. Adaptimmune Therapeutics serves customers worldwide. Stock analysis for Adaptimmune Therapeutics Plc (ADAP:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Is adaptimmune Therapeutics plc (ADAP) ripe for a trend reversal?

The heavy selling pressure might have exhausted for Adaptimmune Therapeutics PLC (ADAP) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.